EUVIMEDEUVIMED entdecken
Open Access

Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival

Qijia He, Shixiao Zhang, Michael L LeBlanc, Ying-Qi Zhao iD

Statistical Methods in Medical Research · 2024

DOI: 10.1177/09622802241262525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2024. Verfasst von Qijia He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Precision Medicine, Probability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individualized treatment rules inform tailored treatment decisions based on the patient’s information, where the goal is to optimize clinical benefit for the population. When the clinical outcome of interest is survival time, most of current approaches typically aim to maximize the expected time of survival. We propose a new criterion for constructing Individualized treatment rules that optimize the clinical benefit with survival outcomes, termed as the adjusted probability of a longer survival. This objective captures the likelihood of living longer with being on treatment, compared to the alternative, which provides an alternative and often straightforward interpretation to communicate with clinicians and patients. We view it as an alternative to the survival analysis standard of the hazard ratio and the increasingly used restricted mean survival time. We develop a new method to construct the optimal Individualized treatment rule by maximizing a nonparametric estimator of the adjusted probability of a longer survival for a decision rule. Simulation studies demonstrate the reliability of the proposed method across a range of different scenarios. We further perform data analysis using data collected from a randomized Phase III clinical trial (SWOG S0819).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineProbabilityHumansSurvival AnalysisModels, StatisticalProportional Hazards ModelsComputer Simulation

Stichwörter der Autor:innen

Personalized medicineadjusted probability of a longer survivalcensored dataindividualized treatment ruleinverse probability of censoring weightingkernel smoother

Autor:innen und Institutionen

  • Department of Statistics, University of Washington, Seattle, WA, USA.
  • Alexion Pharmaceuticals, Inc., Boston, MA, USA.
  • Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

ORCID-Profile: Ying-Qi Zhao

Förderung

  • NCI NIH HHS
  • NIH

Zitieren

APA

He, Q., Zhang, S., LeBlanc, M. L., & Zhao, Y. Q. (2024). Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802241262525

Vancouver

He Q, Zhang S, LeBlanc ML, Zhao YQ. Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival. Statistical Methods in Medical Research. 2024. doi:10.1177/09622802241262525

BibTeX
@article{He2024,
  author = {He, Qijia and Zhang, Shixiao and LeBlanc, Michael L and Zhao, Ying-Qi},
  title = {Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival},
  journal = {Statistical Methods in Medical Research},
  year = {2024},
  doi = {10.1177/09622802241262525}
}
Kostenlos starten →